Why Own the Pipeline The “own the pipeline, own the data, own the model” philosophy isn’t just a tagline — it’s a decision that drives every infrastructure choice we make. When you depend on third-party data vendors, you’re paying margin on top of margin, you’re subject to their terms of service, and you have no […]
Read More →When a company is about to sell new shares — whether through an IPO, a secondary offering, or an ongoing ATM program dripping shares into the market daily — they’re required to deliver a prospectus to buyers. The 424B family of SEC filings is how that prospectus gets publicly disclosed. Learning to read these filings […]
Read More →If you’ve ever watched a promising biotech stock cut in half despite no bad news, only to find a prospectus supplement filed the next morning, you’ve experienced the most common phenomenon in biotech investing. Dilution isn’t a bug in the biotech model — it’s a structural feature that any investor in the sector needs to […]
Read More →Most retail investors never read a 10-Q. They wait for earnings press releases, watch the conference call, and make decisions based on summarized data filtered through management’s preferred narrative. That’s a significant mistake — because the quarterly report filed with the SEC contains information that rarely makes it into the press release, and that information […]
Read More →Most retail investors picture a stock market as a single, transparent venue where all buyers and sellers interact openly. The reality is significantly more fragmented. A substantial portion of daily stock trading — estimates range from 30% to 40% of total US equity volume — happens in private, off-exchange venues called dark pools. Here’s what […]
Read More →A 1-for-10 reverse stock split takes your 10,000 shares worth $0.20 each and turns them into 1,000 shares worth $2.00 each. Your total position value: unchanged. The company’s market cap: unchanged. The underlying business: unchanged. So why does it matter? Because the reasons a company does a reverse split tell you almost everything you need […]
Read More →Members of Congress sit in classified briefings, chair committees that oversee entire industries, and vote on legislation that can make or break specific companies. For decades, they could also quietly trade stocks in those same companies with no public disclosure requirement. The STOCK Act changed that — partially. What is the STOCK Act? The Stop […]
Read More →The death spiral is one of the most reliably destructive forces in small-cap markets. It’s not a conspiracy theory — it’s a contractual mechanism that’s visible in plain sight in SEC filings. Once you understand how it works, you’ll never look at a convertible note announcement the same way again. What is a Toxic Convertible […]
Read More →If you follow small-cap stocks long enough, you’ll start seeing the same pattern: company stock drops 15% after hours, an 8-K gets filed, and buried in the document is a term you might not recognize — PIPE deal. Understanding what a PIPE is, and more importantly what it means for you as a retail investor, […]
Read More →Stock dilution happens when a company issues new shares, reducing the ownership percentage of every existing shareholder. If a company has 10 million shares and issues 2 million new ones, your slice of the pie just got smaller — and the price usually follows. For large-cap investors, dilution is a minor concern. For small-cap and […]
Read More →